George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Not a holder here but lovely to see Marshall Wace being caught short.
Dipped my toe in the water here today having been watching for a while.
P/E, PEG, ROCE, cash in the bank and a reasonable dividend all make for good reading. A profitable company during turbulent times and as AIM shares go, a low spread. Above all, directors with skin in the game.
Maybe not a trading share, but with the new distribution centre well underway and continued growth, the dreaded FOMO kicked in.
Whatever happens, the rumour alone is likely to see a significant rise in the SP tomorrow morning. Happy days!
4 trades @ 4.89 within a short time frame this morning, all showing as sells. Mine was a buy. What is the betting the other 3 were as well.
Happy with that. 34% premium plus keep the divi.
Nice start to a Friday!
Well that update was disappointing, though not entirely unexpected. Still grounds for optimism here but maybe more mid/long term rather than short.
At these prices it was just too inviting not to join in. This SP is nothing to do with the company's performance or potential. It reflects the current macro uncertainty and world events. Any positive news and these prices will be history. Maybe not a day-trading share but for any investor with a little patience.....
I have taken a small position here today (tho’ showing as a sell) following a decent RNS. Revenue, profit & cash all up.
It has been on my watchlist for a while. An attractive P/E and the key factor, a glut of directors’ buys over the past year.
I have no position here but I just love seeing shorters get burnt.
Good luck to all those holding.
Rats - maybe run back to Scancell. Your help is urgently needed!
In the September Q&A, Suzy’s expectation was to make a significant update re VAL201 before year end. In a very upbeat session she added ”with a good degree of certainty” and “if that wasn’t the case we would have advised SHs”.
To clarify, it is now 13th December and a SIGNIFICANT UPDATE ON 201 is still pending before year end.
Meanwhile, in the Porky corner his desperation is based on a low-ball placing. Month by month we continue to hear the same garbage we were hearing last JULY:
4 Jul - 4p placing; 4 Aug - if they can secure a placing at 3.5p I genuinely think they will do well; 25 Sep - Placing at 1-2p IF they can secure support; 4 Oct - Placing inbound at 4p; 1 Nov - See you at the 2p placing; 9 Dec - See you at the placing at 4p
5 months later and Porky is still playing the same record. His venom towards Val is all-consuming. He has nothing else to offer.
Remember, only a handful of days to year end. By all means DYOR but don’t be one of those who makes a New Year resolution “in future, never to spurn a golden opportunity like I just did with Valirx.”
A lovely RNS to wake up to. I love the phrase "materially ahead". It gives me a nice warm glow.
Order book up, net cash up.
A company on the up.
And guess which way the SP will go come 8.00.
In the current macro environment, it is difficult to identify a potential winner amongst the debris of our markets. There may be an exception.
Valirx is currently at an SP of less than 10p. The SP reached a 2-year low of 5p only a few weeks ago, though it has since almost doubled. In Oct ’21, just prior to the VAL201 Letter of Intent with TheorumRX it was 55p. Delays in the deal and subsequent macroeconomic events decimated the SP. However, the company at last appears to be on the verge of finalising the agreement with TRX, led by an enthusiastic CEO who genuinely believes the 201 deal is imminent.
There is much more to Valirx than just 201 though. We have a team of experienced scientists now working from their own new laboratory with access to our own biobank of patient derived cells. This gives far greater control over costs and in-house testing means we are no longer dependent on external bio-lab availability and inevitable delays. We also have developed an amazing portfolio of compounds, any of which could see the current market cap dwarfed. Over the last 2 years we have developed relationships and collaborations with universities both in the UK and abroad.
Our main shareholder is a highly-qualified and experienced scientist, a fellow of the Royal College of Pathologists who is extremely optimistic about the company’s projects and business potential. Formerly of AstraZeneca, now a successful entrepreneur in his own right, Dr Adam Hargreaves is a visiting Professor at the University of Surrey, where he lectures in pharmaceutical toxicology.
Regarding Valirx, in Dr Adam’s own words:
re The position of Valirx in the bio market: ……“look at Companies targeting niche therapy areas, such as Women's Health, and also Oncology - always Oncology. Low MCaps also attractive.”
re Val’s compound portfolio: “Bar the cost of the listing and the lab, there are 5 projects here with a perceived "value" of about 30 pence. Some are very early and some are ready to go. You only need one, and each only needs a 20% chance of success”
re Imagen acquisition: “They’ve bought a business that had an equipment asset value of probably 3+ million; a biobank with significant worth; and all the IP. For 170 grand.
Credit where credit is due. This is an excellent bit of business.”
“ Cancer cachexia is a horrible way to end your days ………what a delight that VAL401has found a way forward.”
re Our bio-lab following the acquisition: …..“It's a proper oncology CRO now, with no direct UK competition in this particular space.”
We are indeed very fortunate to have such an eminent scientist as the main shareholder and acting in an advisory capacity both in the commercial and scientific roles.
Why to consider investing in Valirx (2)
From an internal growth perspective, we now have our own Inaphaea laboratory to develop both Val’s bio-portfolio and also to generate a regular supplementary income from 3rd parties wishing to take advantage of the lab’s state of the art facilities.
Realistically, if the deal completes as our CEO expects, the previous highs could be surpassed as, with the company’s financial position secured, Suzy could also look towards selected further inorganic growth. The distressed market creates fantastic opportunities for an acquisition as she recently showed with Imagen, snapping its assets up for a paltry £170k.
Just within the last month we’ve had two more positive RNS’ re VAL 401 and StingRay Bio with the biggie, still to come. If the 201 deal completes as expected and we reach the previous highs….and why not, we are a significantly more advanced company than in 2021…. we would see a 500% increase in the SP.
Nothing in life comes with any guarantees but those odds look pretty attractive to me.
To clarify, Suzy has not said there will never be a placing. There isn’t a single CEO who could do that, especially on the AIM. However, it would put Suzy in a very precarious position to announce an EGM with a view to a placing at this stage. She has made some mistakes in the past, the timing of the 10p placing being a significant one. Lessons were learnt from that. Suzy will not make the same mistake again. This is not groundhog day.
No-one knows what income she has achieved from Inaphaea. We know she has considerably reduced Val’s cost base. She has also recently splashed out on an evaluation agreement with StingRay Bio. To quote a fellow investor at that time “it would be ludicrous to make today’s announcement without knowing cash was coming in the short term.”
Furthermore, in the last Q&A, an upbeat Suzy stated she expects a ‘significant update re VAL201” with ”a good degree of certainty” and “if that wasn’t the case we would have advised SHs”. All this on top of the recent Val401 RNS. No RNS has been issued to announce an EGM and no RNS issued to advise of any change to her Val 201 optimism.
The SP recently went up nearly 3-fold on no significant news. Can you imagine what a 201 deal confirmation would do to the SP.
Life comes with no guarantees but to those holding, the odds look pretty stacked in our favour. To use the old, but true, nutmeg “I wouldn’t want to be out of this over the weekend”.
To those who may be concerned that an unannounced placing could drop at any time – it can’t!
Please see this post from 2 months ago:
To all fellow Val holders. Early this morning I e-mailed Suzy requesting clarification on the potential of a low-ball placing being dropped on us unexpectedly as has been suggested by certain posters on this forum. With Suzy’s permission (although in the public domain anyway), I have below pasted verbatim excerpts from Suzy’s response:
“Firstly, although we put forward resolutions at the AGM to enable shares to be issued, the resolutions regarding the disapplication of pre-emption rights on those new shares were not passed. This means that were we to conduct a fundraise by means of a dilutive placing, then we would have to ask permission from the shareholders at a general meeting before we could finalise the fundraise. So shareholders would get a say in whether that can happen.”
“……….HE HAS BEEN STATING (INCORRECTLY) THAT WE HAVE HEADROOM AUTHORISED TO CONDUCT A PLACING, whereas we do not, unless that is granted at a future GM. This information is in the public domain in the results of the AGM, but requires full understanding of the headroom and pre-emption implications.”
“……I certainly don’t think it would do any harm to remind people that we do not have authority to issue new shares in a fundraise without further shareholder permission due to pre-emption rights”
(n.b. I have transcribed in capitals though otherwise verbatim)
As always DYOR but personally this has given me the reassurance I was seeking. I have topped up with 27000 shares in 2 batches. I would have preferred more but governed by current liquidity.
In summary, Val CANNOT drop a placing (headroom or otherwise) on us at ANY price without going to the shareholders first for approval. Furthermore, we have pre-emptive rights which cannot be waived.
There is no guarantee that a placing will never happen but in view of all the positive indicators elsewhere I for one am increasing my stake at these extraordinary SPs
I thank Suzy for this clarification. I had previously read on the forum that she was approachable and responsive to shareholders queries and I can now confirm that is certainly the case.
To my mind that is a massive potential barrier removed. NO BOMBSHELL PLACINGS OVERNIGHT!
Good luck to all.
Forsooth, we have jesters in our midst.
Reading the runes, afar, I see a talking pugh. Strange indeed as talking pugh is rare indeed. Although this olde deposit is very confused, as thy doth expect, the smell changes direction according to the wind.
Even more to my dismay a talking pig who has lost many groats on his misadventures. Alas, he still believes he knows of the future. Better still he lay in his sty for unhappiness is his destiny.
Other fools doth gather as moths to a flame. Nay, do not abhor these clowns as they know not of their stupidity but insightfulness beckons. Some watch as their own stead burns down. Of great pity indeed to see such idiocy. Soon they will be of much sadness.
In the runes I also see much delight. Yea, believers, who bore the jealousy and venom of fools. For theirs is the future. A place of joy and veritable treasures. For Valirx is wholesome and in good stead for true believers.
Rats-- you silly Billy. If this relates to a placing you've posted it on the wrong forum! Yours is SCLP.
Rat – I’m posting on a share I’m invested in. Who’s the one stalking who? You’ve come on here to deride a share you’re not even invested in, while there is smoke coming from your own kitchen.
Ratcliffewriter – Instead of wasting your time here on a share where the SP has INCREASED over the last 6 months better look over your shoulder. While you’re away, your own beloved Scancell SP has TUMBLED from c15p to c12p over the same period.
Perhaps spend some time promoting your own investment on your own forum rather than trying to berate investors on theirs. Saying that, I understand the grass is a lot greener here.
In your own words (28/11/23): “All the 'lifestyle company' '5p looming' and other doom mongering vermin can basically go and boil their heads.”